Abstract
Willingness to pay for innovation: the case of the anti-HCV drugs from the Italian National Health Service perspective
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Paper Title
Journal
Date